Stay updated on Immunotherapy in Resectable Head & Neck SCC Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy in Resectable Head & Neck SCC Clinical Trial page.

Latest updates to the Immunotherapy in Resectable Head & Neck SCC Clinical Trial page
- Check5 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2. The page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check12 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1; the page remains a 403 Forbidden error.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedThe page now renders a 403 Forbidden error page, replacing the study record content and navigation. This change blocks access to the trial details and related information on the site.SummaryDifference21%

- Check54 days agoChange DetectedPage revision updated from v3.6.5 to v3.6.6, indicating a minor update or fix to the study details page.SummaryDifference0.0%

- Check76 days agoChange DetectedThe study record was updated to add new outcome data sections for Cohorts 1 and 2, including locoregional recurrence, distant metastases, and Kaplan-Meier estimates for event-free and overall survival, with specified follow-up times. Older outcome phrasing was removed or updated to reflect the new results.SummaryDifference0.7%

- Check90 days agoChange DetectedPage revision updated from v3.6.3 to v3.6.4, indicating a site software release. No visible changes to the study content are indicated by this update.SummaryDifference0.0%

Stay in the know with updates to Immunotherapy in Resectable Head & Neck SCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy in Resectable Head & Neck SCC Clinical Trial page.